ANG LI to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications ANG LI has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
2.707
-
Transplant-associated TMA: the conundrum of diagnosis and treatment. Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):206-213.
Score: 0.491
-
Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA). Thromb Res. 2023 05; 225:39-46.
Score: 0.435
-
Incidence and Risk Factors of Transplantation-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis. Transplant Cell Ther. 2022 05; 28(5):266.e1-266.e8.
Score: 0.402
-
Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors. Transplant Cell Ther. 2021 10; 27(10):864.e1-864.e5.
Score: 0.387
-
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol. 2021 09 01; 96(9):1137-1146.
Score: 0.386
-
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal. Biol Blood Marrow Transplant. 2019 03; 25(3):570-576.
Score: 0.321
-
Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation. Thromb Res. 2023 09; 229:1-6.
Score: 0.111
-
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. Br J Haematol. 2020 06; 189(6):1171-1181.
Score: 0.088
-
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy. Blood Adv. 2019 10 22; 3(20):3062-3069.
Score: 0.086